Thomas Zindrick is the founder of Genelux. Zindrick is the Chairman, President, and Chief Executive Officer of Genelux Corp..
Thomas D. Zindrick is the Chairman, President, and Chief Executive Officer of Genelux Corp., a clinical-stage biopharmaceutical company. He became the largest individual shareholder of Genelux, owning 1.64% of the company. Zindrick succeeded founder Aladar A. Szalay, Ph.D., as CEO and Chairman of the Board in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library